12. Caporuscio, J. (2022, February 25). Are you able to get excessive from eating uncooked weed? Medical News Today. 122. Ricciardi, T. (2024, February 5). Colorado decriminalized 5 psychedelics, but what exactly does that mean? The Denver Post. 13. Grinspoon, P. (2024, April 4). Cannabidiol (CBD): What we know and what we don’t. 58. NIDA. 2021, April 19. What are marijuana’s results?. 145. Ferguson, S. (2020, March 24). You Won’t Overdose on Cannabis, But You’ll be able to Still Overdo It. 2016, March 4). Marijuana use disorder: Common, typically untreated. Cigarette smoking. Many individuals start out vaping and end up smoking cigarettes, which contain larger quantities of dangerous chemicals. The dangers of vaping include lung and different organ damage, respiration issues, addiction and more. Asthma. Vaping could make you more likely to get asthma and other lung conditions. Organ harm. In addition to your lungs, nicotine and other substances in e-liquid can damage your coronary heart and brain. It causes changes in your mind so that you want increasingly more nicotine.
We know nicotine can hurt brain development, elevate your blood stress and narrow your arteries. Lung scarring. Diacetyl, a chemical used in some flavorings, can cause bronchiolitis obliterans (“popcorn lung”). Research led by University College London and the University of Oxford reported that lithium-ion cells inside some disposable vapes can retain high capacity after a whole bunch of cost-discharge cycles, underscoring resource waste and the significance of proper collection and recycling of embedded batteries. However, EVALI can happen in anybody utilizing either nicotine or THC-containing vapes. Among people who have been hospitalized with extreme EVALI, most had been younger than 35 and used THC-containing vapes from informal sources (on-line, household or buddies). Some folks vape as a result of they assume it’ll assist them stop smoking if they’ve already tried other strategies and haven’t been able to quit. An outbreak of EVALI in late 2019 and early 2020 put 1000’s of people in the hospital. 2019). Threat of schizophrenia associated with use of cannabis. 44. Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019). Classic psychedelics: An integrative evaluate of epidemiology, therapeutics, mystical expertise, and mind community function. 55. David Isaac Wolinsky, Barrett, F. S., & Vandrey, R. G. (2023). The psychedelic effects of cannabis: A evaluation of the literature. 104. Hosking, R. D., & Zajicek, J. P. (2008). Therapeutic potential of cannabis in pain medication † †Declaration of interest.
64. Muniyappa, R., Sable, S., Ouwerkerk, R., Mari, A., Gharib, A. M., Walter, M., Courville, A., Hall, G., Chen, K. Y., Volkow, N. D., Kunos, G., Huestis, M. A., & Skarulis, M. C. (2013). Metabolic effects of chronic cannabis smoking. 111. Bidwell, L. C., Martin-Willett, R., Skrzynski, C., Lisano, J., Ortiz Torres, M., Giordano, G., Hutchison, Ok. E., & Bryan, A. D. (2024). Acute and Prolonged Anxiolytic Results of Cannabidiol in Cannabis Flower: A Quasi-Experimental advert libitum Use Study. 62. Barrus, D. G., Capogrossi, K. L., Cates, S. C., Gourdet, C. K., Peiper, N. C., Novak, S. P., Lefever, T. W., & Wiley, J. L. (2016). Tasty THC: Promises and Challenges of Cannabis Edibles. 130. Gordon, A. J., Conley, J. W., & Gordon, J. M. (2013). Medical Consequences of Marijuana Use: A Review of Current Literature. 10. Sommano, S. R., Chittasupho, C., Ruksiriwanich, W., & Jantrawut, P. (2020). The Cannabis Terpenes. 63. Moeller, Ok. E., Kissack, J. C., Atayee, R. S., & Lee, Ok. C. (2017). Clinical interpretation of urine drug tests: What clinicians must learn about urine drug screens. 123. Mahase, E. (2024). MDMA assisted therapy: Three papers are retracted as FDA rejects PTSD software. 48. Wolinsky, D., Barrett, F. S., & Vandrey, R. (2024). The psychedelic effects of cannabis: A assessment of the literature. 88. Kuc, J., Kettner, H., Rosas, F., Erritzoe, D., Haijen, E., Kaelen, M., Nutt, D., & Carhart-Harris, R. L. (2022). Psychedelic expertise dose-dependently modulated by cannabis: results of a potential online survey.
14. Russo, E. B., Cuttler, C., Cooper, Z. D., Stueber, A., Whiteley, V. L., & Sexton, M. (2022). Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. 27. Buckland, P. C., & Panagiotakopulu, E. (2001). Ramses II and the tobacco beetle. 71. Parrott, A. C., Milani, R. M., Gouzoulis-Mayfrank, E., & Daumann, J. (2007). Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. 61. Spindle, T. R., Cone, E. J., Schlienz, N. J., Mitchell, J. M., Bigelow, G. E., Flegel, R., & Vandrey, R. (2018). Acute effects of smoked and vaporized cannabis in wholesome adults who infrequently use cannabis: A crossover trial. 53. Barrett, F. S., Schlienz, N. J., Lembeck, N., Waqas, M., & Vandrey, R. (2018). “Hallucinations” Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs. 60. Chaiton, M., Kundu, A., Rueda, S., & Di Ciano, P. (2022). Are vaporizers a lower-danger different to smoking cannabis?.